195 related articles for article (PubMed ID: 38589847)
1. Which factors predict tumor recurrence and survival after curative hepatectomy in hepatocellular carcinoma? Results from a European institution.
Vaghiri S; Prassas D; Mustafov O; Kalmuk S; Knoefel WT; Lehwald-Tywuschik N; Alexander A; Dizdar L
BMC Surg; 2024 Apr; 24(1):101. PubMed ID: 38589847
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
[TBL] [Abstract][Full Text] [Related]
3. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
[No Abstract] [Full Text] [Related]
4. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
Kuo MJ; Mo LR; Chen CL
BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
[TBL] [Abstract][Full Text] [Related]
5. Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.
Shah SA; Wei AC; Cleary SP; Yang I; McGilvray ID; Gallinger S; Grant DR; Greig PD
J Gastrointest Surg; 2007 May; 11(5):589-95. PubMed ID: 17393258
[TBL] [Abstract][Full Text] [Related]
6. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
8. Factors affecting the recurrence and survival of hepatocellular carcinoma after hepatectomy: a retrospective study of 601 Chinese patients.
Zhang TT; Zhao XQ; Liu Z; Mao ZY; Bai L
Clin Transl Oncol; 2016 Aug; 18(8):831-40. PubMed ID: 26577107
[TBL] [Abstract][Full Text] [Related]
9. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
[TBL] [Abstract][Full Text] [Related]
10. Long-term oncologic results of anatomic vs. parenchyma-sparing resection for hepatocellular carcinoma. A propensity score-matching analysis.
Famularo S; Di Sandro S; Giani A; Lauterio A; Sandini M; De Carlis R; Buscemi V; Romano F; Gianotti L; De Carlis L
Eur J Surg Oncol; 2018 Oct; 44(10):1580-1587. PubMed ID: 29861336
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients with Mesenchymal Circulating Tumor Cell.
Zhang J; Peng H; Wang B; Luo L; Cheng Y; He G; Tang Y; Pan M
J Gastrointest Surg; 2021 Jul; 25(7):1770-1778. PubMed ID: 32748340
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy.
Kim SH; Choi SB; Lee JG; Kim SU; Park MS; Kim DY; Choi JS; Kim KS
J Gastrointest Surg; 2011 Apr; 15(4):598-607. PubMed ID: 21336497
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience.
Park SK; Jung YK; Chung DH; Kim KK; Park YH; Lee JN; Kwon OS; Kim YS; Choi DJ; Kim JH
Korean J Intern Med; 2013 Jul; 28(4):428-38. PubMed ID: 23864801
[TBL] [Abstract][Full Text] [Related]
16. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.
Sonohara F; Nomoto S; Inokawa Y; Kanda M; Yamada S; Fujii T; Sugimoto H; Kodera Y
Medicine (Baltimore); 2015 Mar; 94(9):e602. PubMed ID: 25738484
[TBL] [Abstract][Full Text] [Related]
17. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for preoperative estimation of long-term survival of patients who underwent curative resection with hepatocellular carcinoma beyond Barcelona clinic liver cancer stage A1.
Ruan DY; Lin ZX; Wang TT; Zhao H; Wu DH; Chen J; Dong M; Lin Q; Wu XY; Li Y
Oncotarget; 2016 Sep; 7(38):61378-61389. PubMed ID: 27542216
[TBL] [Abstract][Full Text] [Related]
19. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
Xu XF; Xing H; Han J; Li ZL; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Li C; Wu MC; Shen F; Yang T
JAMA Surg; 2019 Mar; 154(3):209-217. PubMed ID: 30422241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
